Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2004
03/25/2004US20040058923 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
03/25/2004US20040058920 Benzoxazinone-derived compounds, their preparation and use as medicaments
03/25/2004US20040058917 Wound healing agents; antiscarring agents
03/25/2004US20040058915 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists
03/25/2004US20040058913 Cyclic diamine compound with condensed-ring groups
03/25/2004US20040058912 Psychological disorders; eating disorders; dietetics
03/25/2004US20040058907 Compounds useful in the treatment of inflammatory diseases
03/25/2004US20040058905 FKBP inhibitors
03/25/2004US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
03/25/2004DE10242488A1 New N-alkyl-dibenzoxazepinone derivatives, are aminopeptidase N inhibitors useful for treating cardiovascular, inflammatory, autoimmune or cancer diseases or chronic pain, especially arteriosclerosis
03/25/2004CA2498460A1 Inhibitors of tfg.beta.
03/25/2004CA2498269A1 Substituted aminoethers for the treatment of alzheimer's disease
03/25/2004CA2497078A1 2-pyrrolidin-2-yl-[1,3,4]-oxadiazole derivatives and the use of the same as antidepressants
03/24/2004EP1400526A2 ((cyclo)alkyl substituted)- gamma -aminobutyric acid derivatives (=Gaba analogues), their preparation and their use in the treatment of neurological disorders
03/24/2004EP1400519A1 Respiratory syncytial virus replication inhibitors
03/24/2004EP1400515A1 Cyclic diamine compound having five-membered cyclic group
03/24/2004EP1400510A1 Cyclic diamine compounds having fused-ring groups
03/24/2004EP1400241A1 Fused cyclic compounds and medicinal use thereof
03/24/2004EP1399441A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists
03/24/2004EP1399440A1 5-(2-aminopyrimidin-4-yl)benzisoxazoles as protein kinase inhibitors
03/24/2004EP1399438A1 Novel heteroaryl derivatives, their preparation and use
03/24/2004EP1399436A2 Oxytocin agonists
03/24/2004EP1399433A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
03/24/2004EP1399432A1 Spiropiperidine compounds as ligands for orl-1 receptor
03/24/2004EP1399420A2 Pyrrolidines as dipeptidyl peptidase inhibitors
03/24/2004EP1280796B1 Pyrimidinyl methyl indole derivatives with antibacterial activity
03/24/2004EP1197493B1 Benzimidazole compounds
03/24/2004EP1131318B1 Process for making 5-substituted pyrazoles using dithietanes
03/24/2004EP0922036B1 Arylalkanoyl pyridazines
03/24/2004CN1484641A Microbiocidal N-Phenyl-N-[4-pyridyl-pyrimidin-2-yl]-amine derivatives
03/24/2004CN1484638A I-aryl-or-I-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-b ligands
03/24/2004CN1142920C Quinazoline derivatives and pharmaceutical compositions containing them and preparation process and use
03/24/2004CN1142919C Quinazoline derivatives as antitumor agents
03/24/2004CN1142912C Amide derivs, useful as inhibitors for production of cytokines
03/24/2004CN1142909C Indole derivatives with antiviral activity
03/24/2004CN1142904C One-step process synthetizing 2-oxazolidone derivative interediate and preparation process thereof
03/24/2004CN1142793C Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure
03/23/2004US6710063 Activators of PPAR delta
03/23/2004US6710058 Use as anticoagulant agents for therapy and prophylaxis ofthromboembolic disorders
03/23/2004US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
03/23/2004US6710047 Phthalazines with angiogenesis inhibiting activity
03/23/2004US6710044 Technical field
03/23/2004US6710042 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
03/23/2004CA2263319C Quinazoline derivatives and pharmaceutical compositions containing them
03/18/2004WO2004022555A1 Isoxazoles and their use in the treatment of ischemic diseases
03/18/2004WO2004022554A1 Quinazolinone derivatives
03/18/2004WO2004022553A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING IκB KINASE
03/18/2004WO2004022551A1 Furan or thiophene derivative and medicinal use thereof
03/18/2004WO2004022544A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
03/18/2004WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004WO2004022060A2 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders
03/18/2004WO2004022057A1 USE OF IκB KINASE INHIBITORS FOR THE TREATMENT OF PAIN
03/18/2004WO2004021997A2 Inhibitors of fungal invasion
03/18/2004WO2004011447A3 Method for preparing fused oxazinones from ortho-amino aromatic carboxylic acid and a carboxylic acid in the presence of a sulfonyl chloride and pyridine
03/18/2004WO2004007489A3 Antibacterial substituted cyanomethyl (ene) piperidinophenyl oxazolidinones, process or their preparation, and pharmaceutical compositions containing them
03/18/2004WO2004007488A3 Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them
03/18/2004WO2003099266A3 Acetamides and benzamides that are useful in treating sexual dysfunction
03/18/2004WO2003035615A3 Tyrosine kinase inhibitors
03/18/2004US20040054187 Therapeutic ureas
03/18/2004US20040053987 Bis-heterocyclic compounds with antitumour and chemosensitising activity
03/18/2004US20040053979 Indolyl derivatives
03/18/2004US20040053972 Medicinal compositions having improved absorbability
03/18/2004US20040053955 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
03/18/2004US20040053953 Treatment of chemokine mediated diseases
03/18/2004US20040053952 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
03/18/2004US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto
03/18/2004US20040053921 Compounds useful as reversible inhibitors of cysteine proteases
03/18/2004US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
03/18/2004US20040053270 Identifying ribonucleoprotein complexes using fluorescent oxazolidinone or aminoglycoside reporter; antibiotic analysis
03/18/2004DE10242350A1 New 3-aminomethylene-indoline-2-(thi)one derivatives, are kinase inhibitors useful for treating proliferative diseases e.g. tumors, rheumatoid arthritis, neovascular glaucoma and arteriosclerosis
03/18/2004CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004CA2497901A1 Furan or thiophene derivative and medicinal use thereof
03/18/2004CA2497827A1 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders
03/17/2004EP1398313A1 Novel heterocyclic derivatives and medicinal use thereof
03/17/2004EP1398033A2 Use of benzodiazepines for treating autoimmune diseases, inflammations, neoplasies, viral infections and atherosclerosis
03/17/2004EP1398028A2 Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same
03/17/2004EP1398027A1 Use of matrix metalloproteinase inhibitors for treating or preventing glomerulopathy
03/17/2004EP1397488A1 Novel compounds for chemiluminescense procedures
03/17/2004EP1397353A1 2-(2,6-disubstituted phenyl)-4-aryl-5-alkyl-1,3-oxazoline compounds useful as insecticides and acaricides
03/17/2004EP1397340A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
03/17/2004EP1246815B1 Phenylpiperazinyl derivatives
03/17/2004EP1224175B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
03/17/2004EP0971588B1 Novel cannabinoid receptor modulators
03/17/2004EP0797574B1 1,3,4-oxadiazine derivatives having a pesticide effect
03/17/2004CN1483032A Process for making substituted 8-arylquinolinium benzenesulfonate
03/17/2004CN1483030A Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for the treatment of nervous system disorders
03/17/2004CN1483028A Quinolinone derivatives as tyrosine kinase inhibitors
03/17/2004CN1483024A Vla-4 inhibitors
03/17/2004CN1483019A Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
03/17/2004CN1142162C Bicyclic oxazolidinones as antibacterial agents
03/17/2004CN1142158C Process to prepare cyclic-sulfur fluorine containing oxazolidinones
03/17/2004CN1142144C 4-phenyl pyridine derivatives
03/16/2004US6706886 Process and novel intermediates for preparing isoxazolin-3-ylacyl benzenes
03/16/2004US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors
03/16/2004US6706757 Chroman derivatives as 5-hydroxytryptamine-6 ligands
03/16/2004US6706747 Treating elevated intraocular pressure, depression, non insulin-dependent diabetes, male impotence and obesity which is alleviated by treatment with an alpha 2 blocking agent
03/16/2004US6706743 β3 adrenergic receptor agonists and uses thereof
03/16/2004US6706738 Substituted bicyclic heteroaryl compounds and their use as integrin antagonists
03/16/2004US6706724 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent
03/16/2004US6706723 Pyrimidine-2,4,6-trione metalloproteinase inhibitors